23andMe Launches Personal Genome Service For Carrier Screening After Work With FDA
This article was originally published in The Gray Sheet
Two years of conversations with FDA have led 23andMe back to the health care market with the Oct. 21 launch of its new Personal Genome Service, focused on carrier screening tests. The firm says its close engagement with FDA has improved its customer communication and quality control.
Register for our free email digests: